Patent · US Active

2,3-substituted indole derivatives for treating viral infections

US8143305B2 · kind B2 · utility

1Cited by

11References

12Claims

0Family size

Assignee

SCHERING CORPORATION · US

Inventors

Gopinadhan N. Anilkumar · Edison, US
Frank Bennett · Piscataway, US
Tin-Yau Chan · Edison, US
Kevin X. Chen · Edison, US
Mousumi Sannigrahi · Summit, US
Francisco Velazquez · Clinton, US
Srikanth Venkatraman · Fords, US
Qingbei Zeng · Shanghai, CN
Jose S. Duca · Cranford, US
Charles A. Lesburg · Newton, US
Joseph A. Kozlowski · Princeton, US
F. George Njoroge · Hackettstown, US
Stuart B. Rosenblum · West Orange, US
Neng-Yang Shih · Lexington, US
Stephen J. Gavalas · Manhasset, US
Yueheng Jiang · Shanghai, CN
Patrick A. Pinto · Mine Hill, US
Haiyan Pu · Livingston, US
Oleg B. Selyutin · Princeton Colonial Park, US
Bancha Vibulbhan · Kenilworth, US
Li Wang · Frankfurt am Main, DE
Wanli Wu · Edison, US
Weiying Yang · Edison, US
Yuhua Huang · Westfield, US
Hsueh Cheng Huang · Scarsdale, US
Robert Palermo · New York, US
Boris Feld · New Milford, US

Key dates

Filing date	Aug 27, 2008
Grant date	Mar 27, 2012
Priority date	—
Expiry date	Aug 27, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to 2,3-Substituted Indole Derivatives, compositions comprising at least one 2,3-Substituted Indole Derivative, and methods of using the 2,3-Substituted Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.